Topography Guided LASIK by Different Protocols for Treatment of Astigmatism

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT03597906
Collaborator
(none)
30
1
3
17.2
1.7

Study Details

Study Description

Brief Summary

Background and Rationale:

LASIK has been among the highest satisfaction rates of surgical procedures, ranging from 82%-98%. Different ablation profiles have been developed over the years. The purpose of this study is to validate this novel measurement by comparing the visual outcomes when the TMR is used in myopic astigmatic LASIK to using the standard manifest refraction or the Topolyzer measurements alone.

Objectives :

To evaluate the safety, efficacy and predictability of topography-guided myopic LASIK with three different refraction treatment strategies.

Condition or Disease Intervention/Treatment Phase
  • Procedure: topography guided ablation
  • Procedure: manifest refraction
  • Procedure: full topography modified refraction
  • Procedure: partial topography modified refraction
N/A

Detailed Description

Candidates for refractive surgery above 18 years with myopic astigmatism and no previous ocular surgery.

Sample size 60 eyes. surgery:
  • 60 eyes of myopic topography-guided LASIK procedures with the same refractive platform (FS200 femtosecond to create a flap between90: 110 μm with diameter 8:9 mm and EX500 excimer lasers) will be randomized for treatment as follows:

  • Group A: 20 eyes will be treated using Contoura vision with the standard manifest refraction.

  • Group B: 20 eyes will be treated with Contoura vision using the topographic astigmatic power and axis and without change in the spherical power (using the same spherical power as the manifest refraction).

  • Group C [TMR]: 20 eyes will be treated with Contoura vision using the topographic astigmatic power and axis and modifying the spherical power to obtain the same spherical equivalent as the manifest refraction. This is done by subtracting half of the difference between topographic astigmatic power and the manifest astigmatic power from the spherical power (topography-modified treatment refraction).

  • The standard postoperative treatment is combined steroids and antibiotics eye drops 5 times daily for one week ,then three times daily for three days and lubricant eye drops 5 times daily for six months.

Postoperatively, the patients will be examined at 1 week, 1 month and 3 months. All postoperative follow-up visits included measurement of UDVA, CDVA (if indicated) and refraction, besides full ophthalmological examination and performing pentacam and topolyzer after 3 months

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A prospective, randomized and comparative interventional studyA prospective, randomized and comparative interventional study
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of the Outcome of Topography Modified Refraction Correction to Standard Clinical Refraction Correction in Myopic Astigmatic Topography-guided LASIK
Actual Study Start Date :
Aug 15, 2018
Actual Primary Completion Date :
Nov 15, 2019
Actual Study Completion Date :
Jan 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group A: Manifest

20 eyes will be treated using Contoura, topography guided ablation vision with the standard manifest refraction.

Procedure: topography guided ablation
using the data obtained from the topolyzer for correction of refractive errors specially astigmatism we use 3 different treatment protocols

Procedure: manifest refraction
using for ablation the exact manifest refraction

Experimental: Group B: partial TMR

20 eyes will be treated with Contoura vision, topography guided ablation using the topographic astigmatic power and axis and without change in the spherical power (using the same spherical power as the manifest refraction).

Procedure: topography guided ablation
using the data obtained from the topolyzer for correction of refractive errors specially astigmatism we use 3 different treatment protocols

Procedure: partial topography modified refraction
partial topography modified refraction means changing only cylinder power and axis in the ablation profile

Experimental: Group C: Full TMR

20 eyes will be treated with Contoura vision, topography guided ablation using the topographic astigmatic power and axis and modifying the spherical power to obtain the same spherical equivalent as the manifest refraction. This is done by subtracting half of the difference between topographic astigmatic power and the manifest astigmatic power from the spherical power (topography-modified treatment refraction).

Procedure: topography guided ablation
using the data obtained from the topolyzer for correction of refractive errors specially astigmatism we use 3 different treatment protocols

Procedure: full topography modified refraction
full topography modified refraction means changing both sphere and cylinder power in the ablation profile

Outcome Measures

Primary Outcome Measures

  1. post operative residual astigmatism [3 months]

    measuring the post operative residual astigmatism and comparison between the 3 group to reach to the most accurate protocol.

Secondary Outcome Measures

  1. measurement of the postoperative unaided visual acuity [3 months]

    measurement of the postoperative unaided visual acuity and comparison between the 3 group to reach to the most accurate protocol.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Stable refractive error: Myopic astigmatism ≥ -1.5 D

  • Valid Topolyzer maps (at least four out of eight right maps with green analyzed area and the registration box is green).

Exclusion Criteria:
  1. Estimated postoperative residual stromal bed thickness of less than 300µm.

  2. Glaucomatous patients.

  3. Patients with keratoconus.

  4. Patients with pervious refractive surgery.

  5. History of previous ocular trauma or surgery.

  6. History of recent herpetic ulcer or viral keratitis.

  7. Basement membrane disease, history of recurrent corneal erosions.

  8. Sicca syndrome, dry eye.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr Alainy Cairo Egypt 11562

Sponsors and Collaborators

  • Cairo University

Investigators

  • Study Director: Mohmed Hosny, MD, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fayrouz Aboalazayem, the principal investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT03597906
Other Study ID Numbers:
  • N-18-2018
First Posted:
Jul 24, 2018
Last Update Posted:
Jan 28, 2020
Last Verified:
Jan 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Fayrouz Aboalazayem, the principal investigator, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 28, 2020